- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novakand Pharma AB (NOVKAN)
Novakand Pharma AB stock price live, this page displays ST NOVKAN stock exchange data. View the NOVKAN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Novakand Pharma AB real time stock price chart below.
What Is the Novakand Pharma AB Stock Price Today?
The Novakand Pharma AB stock price today is 0.255.
What Is the Stock Symbol for Novakand Pharma AB?
The stock symbol for Novakand Pharma AB is ""NOVKAN.""
What Stock Exchange Does Novakand Pharma AB Trade On?
Novakand Pharma AB is listed and trades on the Stockholm stock exchange.
Is Novakand Pharma AB a Good Stock to Buy?
Determining whether Novakand Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVKAN quote. (ISIN: SE0015658570)
What Is the Novakand Pharma AB Stock Price Today?
The Novakand Pharma AB stock price today is 0.255.
What Is the Stock Symbol for Novakand Pharma AB?
The stock symbol for Novakand Pharma AB is ""NOVKAN.""
What Stock Exchange Does Novakand Pharma AB Trade On?
Novakand Pharma AB is listed and trades on the Stockholm stock exchange.
Is Novakand Pharma AB a Good Stock to Buy?
Determining whether Novakand Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVKAN quote. (ISIN: SE0015658570)
Stockholm
Currency in SEK
0.255
-0.002(-0.78%)
Closed·
Fair Value
An estimate of a Novakand Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.240
0.259
52 wk Range
0.240
2.250
NOVKAN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
1/2
Fair Value
An estimate of a Novakand Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2400.259
52 wk Range
0.2402.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NOVKAN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Novakand Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Novakand Pharma AB Company Profile
Novakand Pharma AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops KAN571, a ROR1 inhibitor for the treatment of mantle cell lymphoma and B-cell malignancy. The company was formerly known as Kancera AB (publ) and changed its name to Novakand Pharma AB (publ) in September 2025. Novakand Pharma AB (publ) was incorporated in 2010 and is headquartered in Solna, Sweden.
Compare NOVKAN to Peers and Sector
Metrics to compare | NOVKAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNOVKANPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.4x | −0.7x | |
PEG Ratio | −0.02 | −0.10 | 0.00 | |
Price/Book | 0.7x | 40.7x | 2.6x | |
Price / LTM Sales | - | 0.0x | 3.4x | |
Upside (Analyst Target) | - | 142.7% | 35.5% | |
Fair Value Upside | Unlock | −8.3% | 3.3% | Unlock |
Earnings
Latest Release
Aug 22, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Novakand Pharma AB Trade On?
Novakand Pharma AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Novakand Pharma AB?
The stock symbol for Novakand Pharma AB is "NOVKAN."
What Is the Novakand Pharma AB Market Cap?
As of today, Novakand Pharma AB market cap is 30.90M.
What Is Novakand Pharma AB's Earnings Per Share (TTM)?
The Novakand Pharma AB EPS (TTM) is -0.33.
When Is the Next Novakand Pharma AB Earnings Date?
Novakand Pharma AB will release its next earnings report on 20 Nov 2025.
From a Technical Analysis Perspective, Is NOVKAN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Novakand Pharma AB Stock Split?
Novakand Pharma AB has split 9 times.
How Many Employees Does Novakand Pharma AB Have?
Novakand Pharma AB has 5 employees.
What is the current trading status of Novakand Pharma AB (NOVKAN)?
As of 04 Oct 2025, Novakand Pharma AB (NOVKAN) is trading at a price of 0.255, with a previous close of 0.26. The stock has fluctuated within a day range of 0.240 to 0.259, while its 52-week range spans from 0.240 to 2.250.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.